Etidronic acid
From Wikipedia, the free encyclopedia
(Redirected from Etidronate)
| Image:Etidronic acid.svg | |
| Etidronic acid
| |
| Systematic (IUPAC) name | |
| (1-hydroxy-1-phosphono-ethyl)phosphonic acid | |
| Identifiers | |
| CAS number | 7414-83-7 |
| ATC code | M05BA01 M05BB01 |
| PubChem | 3305 |
| DrugBank | APRD00964 |
| Chemical data | |
| Formula | C2H8O7P2 |
| Mol. weight | 206.028 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 3% |
| Metabolism | Nil |
| Half life | 1 to 6 hours |
| Excretion | Renal and fecal |
| Therapeutic considerations | |
| Licence data | |
| Pregnancy cat. |
C(US) |
| Legal status |
℞ Prescription only |
| Routes | Oral, intravenous |
Etidronic acid (INN) or etidronate disodium (trade name Didronel®) is a bisphosphonate used to strengthen bone, treat osteoporosis, and treat Paget's disease of bone.
| Bisphosphonates (M05A)edit | ||
|---|---|---|
| Nitrogenous: |
Pamidronic acid, Alendronic acid, Ibandronic acid, Risedronic acid, Zoledronic acid | |
| Non-nitrogenous: |
Etidronic acid, Clodronic acid, Tiludronic acid | |
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
